Page last updated: 2024-09-02

perindopril and Colorectal Neoplasms

perindopril has been researched along with Colorectal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davies, JM; Gill, S; Ho, MY; Kollmannsberger, CK; Lim, HJ; Melosky, BL; Renouf, DJ; Vandt, SA	1

Trials

1 trial(s) available for perindopril and Colorectal Neoplasms

Article	Year
A phase II trial of the effect of perindopril on hand-foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC. Cancer chemotherapy and pharmacology, 2019, Volume: 83, Issue:3 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Hand-Foot Syndrome; Humans; Incidence; Male; Middle Aged; Perindopril; Phenylurea Compounds; Progression-Free Survival; Protein Kinase Inhibitors; Pyridines; Severity of Illness Index	2019

Article

Year

A phase II trial of the effect of perindopril on hand-foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC.

Cancer chemotherapy and pharmacology, 2019, Volume: 83, Issue:3

Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Hand-Foot Syndrome; Humans; Incidence; Male; Middle Aged; Perindopril; Phenylurea Compounds; Progression-Free Survival; Protein Kinase Inhibitors; Pyridines; Severity of Illness Index

2019